Procon debate Octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin 英文参考文献.docVIP

下载本文档

2
0
约2.08万字
约 4页
2017-05-13 发布于上海
举报
版权申诉

Procon debate Octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin 英文参考文献.doc

1、本文档共4页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Procon debate Octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin 英文参考文献

Available online /content/10/4/218 Review Pro/con debate: Octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin? Yaseen Arabi1, Bandar Al Knawy2, Alan N Barkun3 and Marc Bardou4 1Intensive Care Unit, King Abdulaziz Medical City, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia 2Division of Gastroenterology/Hepatology, Department of Medicine, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia 3Divisions of Gastroenterology and Clinical Epidemiology, McGill University, and the McGill University Health Centre, Montréal, Québec, Canada 4Division of Clinical Pharmacology, LPPCE, Faculty of Medicine, Dijon Cedex, France Corresponding author: Alan Barkun, alan.barkun@muhc.mcgill.ca Published: 3 July 2006 Critical Care 2006, 10:218 (doi:10.1186/cc4958) This article is online at /content/10/4/218 ? 2006 BioMed Central Ltd Abstract Clinical scenario A 59 year old male has been admitted to the intensive care unit with febrile neutropenia and septic shock. The patient has been diagnosed with acute myelogenous leukemia and following induction is pancytopenic. He is mechanically ventilated and receiving H2 antagonists. You are called because the patient is having large amounts of melena and a modest amount of blood returning from his nasogastric tube. He is hemodynamically unstable. You transfuse blood, platelets and plasma as appropriate, and start an intravenous proton pump inhibitor. Endoscopy cannot be performed until the following day. You have to decide whether to treat the patient empirically with intravenous octreotide. You know it has a role in certain types of gastrointestinal (GI) bleeding but you are uncertain if you should be using it when the cause of bleeding is unclear. Your administrator tells you the drug is relatively expensive. Whether it is the primary reason for admission